Jül Gerrior

811 total citations
15 papers, 603 citations indexed

About

Jül Gerrior is a scholar working on Emergency Medicine, Endocrinology, Diabetes and Metabolism and Infectious Diseases. According to data from OpenAlex, Jül Gerrior has authored 15 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Emergency Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Infectious Diseases. Recurrent topics in Jül Gerrior's work include HIV-related health complications and treatments (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and HIV Research and Treatment (3 papers). Jül Gerrior is often cited by papers focused on HIV-related health complications and treatments (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and HIV Research and Treatment (3 papers). Jül Gerrior collaborates with scholars based in United States, Israel and India. Jül Gerrior's co-authors include Christine Wanke, Alexandra Mangili, C. A. Wanke, Joseph F. Polak, Mary Albrecht, Eoin Coakley, Ernst J. Schaefer, Alice Tang, Sally Skinner and S. L. Gorbach and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and AIDS.

In The Last Decade

Jül Gerrior

15 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jül Gerrior United States	12	447	249	173	118	107	15	603
Janine M. Trevillyan Australia	12	227 0.5×	174 0.7×	139 0.8×	22 0.2×	22 0.2×	36	453
Alberto Martín-Hidalgo Spain	8	115 0.3×	133 0.5×	53 0.3×	44 0.4×	43 0.4×	13	400
Lisa Malincarne Italy	9	130 0.3×	122 0.5×	68 0.4×	18 0.2×	24 0.2×	24	338
Michael Somero United States	6	182 0.4×	679 2.7×	113 0.7×	72 0.6×	24 0.2×	7	896
Lori E. Fantry United States	10	141 0.3×	138 0.6×	58 0.3×	43 0.4×	7 0.1×	30	319
M. Buisson France	10	58 0.1×	96 0.4×	50 0.3×	76 0.6×	18 0.2×	18	296
G Carnevale Italy	8	105 0.2×	119 0.5×	56 0.3×	30 0.3×	39 0.4×	18	252
Heloísa Ramos Lacerda de Melo Brazil	12	105 0.2×	161 0.6×	54 0.3×	22 0.2×	6 0.1×	24	321
Michael S Boger United States	10	73 0.2×	98 0.4×	49 0.3×	30 0.3×	11 0.1×	18	345
Marita Stevens Belgium	18	143 0.3×	659 2.6×	451 2.6×	7 0.1×	13 0.1×	38	985

Countries citing papers authored by Jül Gerrior

Since Specialization

Citations

This map shows the geographic impact of Jül Gerrior's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jül Gerrior with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jül Gerrior more than expected).

Fields of papers citing papers by Jül Gerrior

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jül Gerrior. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jül Gerrior. The network helps show where Jül Gerrior may publish in the future.

Co-authorship network of co-authors of Jül Gerrior

This figure shows the co-authorship network connecting the top 25 collaborators of Jül Gerrior. A scholar is included among the top collaborators of Jül Gerrior based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jül Gerrior. Jül Gerrior is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Asztalos, Bela F., Alexandra Mangili, Jül Gerrior, et al.. (2014). Short Communication: Effects of Omega-3 Fatty Acids on Triglycerides and High-Density Lipoprotein Subprofiles in HIV-Infected Persons with Hypertriglyceridemia. AIDS Research and Human Retroviruses. 30(8). 800–805. 16 indexed citations

Mangili, Alexandra, Joseph F. Polak, Sally Skinner, et al.. (2011). HIV Infection and Progression of Carotid and Coronary Atherosclerosis: The CARE Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(2). 148–153. 42 indexed citations

Sudarsanam, Thambu David, Jacob John, Gagandeep Kang, et al.. (2011). Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV–tuberculosis coinfection receiving directly observed short‐course chemotherapy for tuberculosis. Tropical Medicine & International Health. 16(6). 699–706. 44 indexed citations

Mangili, Alexandra, et al.. (2010). Markers of atherosclerosis and inflammation and mortality in patients with HIV infection. Atherosclerosis. 214(2). 468–473. 52 indexed citations

Mangili, Alexandra, Denise L. Jacobson, Jül Gerrior, et al.. (2007). Metabolic Syndrome and Subclinical Atherosclerosis in Patients Infected with HIV. Clinical Infectious Diseases. 44(10). 1368–1374. 78 indexed citations

Mangili, Alexandra, Jül Gerrior, Alice Tang, et al.. (2006). Risk of Cardiovascular Disease in a Cohort of HIV-Infected Adults: A Study Using Carotid Intima-Media Thickness and Coronary Artery Calcium Score. Clinical Infectious Diseases. 43(11). 1482–1489. 90 indexed citations

Wanke, Christine, et al.. (2005). Alterations in Lipid Profiles in HIV‐Infected Patients Treated With Protease Inhibitor Therapy Are Not Influenced by Diet. Nutrition in Clinical Practice. 20(6). 668–673. 9 indexed citations

Asztalos, Bela F., Ernst J. Schaefer, Katalin V. Horvath, et al.. (2005). Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients. Atherosclerosis. 184(1). 72–77. 56 indexed citations

Tang, Alice, et al.. (2005). Micronutrients: current issues for HIV care providers. AIDS. 19(9). 847–861. 34 indexed citations

10.

Gerrior, Jül & Lisa M. Neff. (2005). Nutrition assessment in HIV infection.. PubMed. 8(1). 6–15. 8 indexed citations

11.

Mwamburi, D. Mkaya, Jül Gerrior, Ira B. Wilson, et al.. (2004). Comparing Megestrol Acetate Therapy with Oxandrolone Therapy for HIV‐Related Weight Loss: Similar Results in 2 Months. Clinical Infectious Diseases. 38(6). 895–902. 20 indexed citations

12.

Mwamburi, D. Mkaya, Jül Gerrior, Ira B. Wilson, et al.. (2004). Combination Megestrol Acetate, Oxandrolone, and Dietary Advice Restores Weight in Human Immunodeficiency Virus. Nutrition in Clinical Practice. 19(4). 395–402. 7 indexed citations

13.

Gerrior, Jül, et al.. (2001). The Fat Redistribution Syndrome in Patients Infected with HIV. Journal of the American Dietetic Association. 101(10). 1175–1180. 11 indexed citations

14.

Wanke, Christine, et al.. (1999). Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV. AIDS. 13(15). 2099–2103. 97 indexed citations

15.

Wanke, Christine, et al.. (1998). Successful Treatment of Diarrheal Disease Associated with EnteroaggregativeEscherichia coliin Adults Infected with Human Immunodeficiency Virus. The Journal of Infectious Diseases. 178(5). 1369–1372. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact